Alzheimer's Disease and dementia are debilitating conditions marked by progressive cognitive decline. Alzheimer's, the most prevalent form of dementia, disrupts memory, cognitive function, and behavior due to abnormal protein accumulation in the brain, causing nerve cell loss and neurotransmitter disturbances.
These disorders present significant challenges to patients, caregivers, and healthcare systems worldwide, impacting daily life and well-being profoundly. Brain-Computer Interfaces (BCIs) represent a cutting-edge approach in managing Alzheimer's and dementia. BCIs aim to establish direct communication pathways between the brain and external devices, potentially aiding in cognitive assessment, communication enhancement, and even memory support for affected individuals.
Though still in experimental phases, BCIs offer a promising avenue for improving the quality of life for those with Alzheimer's and dementia. They propose innovative solutions for understanding and interacting with the environment, potentially fostering greater independence and social engagement despite cognitive decline.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States